X hits on this document

Powerpoint document

Clevidipine Phase III Studies: Perioperative Hypertension - page 61 / 65

240 views

0 shares

0 downloads

0 comments

61 / 65

VELOCITY:   Adverse Events (Safety Population)

39.7% of patients experienced one adverse event

Related to clevidipine treatment (30.2%)

Unrelated to clevidipine treatment (9.5%)

Most common:

Headache 6.3% (8/126)

Nausea 4.8% (6/126)

Chest discomfort 3.2% (4/126)

Vomiting 3.2% (4/126)

8.7% of patients experienced one serious adverse event

1 patient experienced chest discomfort that was assessed as possibly related to treatment

All other serious AE’s, including 3 deaths, were assessed as unrelated or unlikely to be related to clevidipine

Annals of Emergency Medicine - 06 June 2008 (10.1016/j.annemergmed.2008.04.025)

Document info
Document views240
Page views240
Page last viewedWed Jan 18 06:15:58 UTC 2017
Pages65
Paragraphs1351
Words4734

Comments